Design and Validation of a Novel EPC Microfluidic Capture Chip and its Application in Patients with PAH

Update: 2014-03-19

Description

An interdisciplinary group of researchers have developed a microfluidic device that can test for the number of beneficial circulating endothelial progenitor cells (EPCs) in the blood stream of patients with cardiovascular disease. The number of EPCs in the blood can be used as a biomarker for risk assessment, disease progression and the response to therapy.

Comments

In Channel

Diuretics in PAH

2014-05-1449:55

Working with Social Workers to Enhance the PH Team

2014-05-0748:07

The Role of the Respiratory Therapist in the Treatment of Pulmonary Hypertension Patients

2014-04-3058:41

Understanding Compassion Fatigue

2014-04-2331:14

The Treatment of Pulmonary Arterial Hypertension with the Anti-proliferative Agent Hydroxyurea

2014-04-0928:08

Pulmonary Hypertension in Schistosomiasis: An Overview

2014-04-0201:09:49

New Quality Indicator Set for Systemic Sclerosis

2014-03-2632:19

Design and Validation of a Novel EPC Microfluidic Capture Chip and its Application in Patients with PAH

2014-03-1942:05

Caveolin-1 Expression During the Progression of Pulmonary Hypertension

2013-11-1135:09

17-Beta Estradiol Attenuates Hypoxic Pulmonary Hypertension via Estrogen Receptor-mediated Effects

2013-11-1049:58

00:00

Design and Validation of a Novel EPC Microfluidic Capture Chip and its Application in Patients with PAH

Georg Hansmann, MD, PhD and Shashi Murthy, PhD

#box-pro-ellipsis-176125448861424{-webkit-line-clamp:2;}Design and Validation of a Novel EPC Microfluidic Capture Chip and its Application in Patients with PAH

Design and Validation of a Novel EPC Microfluidic Capture Chip and its Application in Patients with PAH

Georg Hansmann, MD, PhD and Shashi Murthy, PhD

Design and Validation of a Novel EPC Microfluidic Capture Chip and its Application in Patients with PAH